Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases

Background Identifying systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF) patients at risk of more rapid forced vital capacity (FVC) decline could improve trial design. The purpose of the present study was to explore the prognostic value of quantitative high-resolution computed tomogra...

Full description

Bibliographic Details
Main Authors: Yixuan Zou, Xuefeng Hou, Neha Anegondi, Mohammadreza Negahdar, Dorothy Cheung, Paula Belloni, Alex de Crespigny, Alexandre Fernandez Coimbra
Format: Article
Language:English
Published: European Respiratory Society 2023-10-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/9/5/00210-2023.full
_version_ 1797629375666978816
author Yixuan Zou
Xuefeng Hou
Neha Anegondi
Mohammadreza Negahdar
Dorothy Cheung
Paula Belloni
Alex de Crespigny
Alexandre Fernandez Coimbra
author_facet Yixuan Zou
Xuefeng Hou
Neha Anegondi
Mohammadreza Negahdar
Dorothy Cheung
Paula Belloni
Alex de Crespigny
Alexandre Fernandez Coimbra
author_sort Yixuan Zou
collection DOAJ
description Background Identifying systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF) patients at risk of more rapid forced vital capacity (FVC) decline could improve trial design. The purpose of the present study was to explore the prognostic value of quantitative high-resolution computed tomography (HRCT) metrics derived by Imbio lung texture analysis (LTA) tool in predicting FVC slope. Methods This retrospective study used data from patients who were not treated with investigational drugs with and without background antifibrotic therapies in tocilizumab phase 3 SSc, lebrikizumab phase 2 IPF, and zinpentraxin alfa phase 2 IPF studies conducted from 2015 to 2021. Controlled HRCT axial volumetric multidetector computed tomography scans were evaluated using the Imbio LTA tool. Associations between HRCT metrics and FVC slope were assessed through the Spearman correlation coefficient and adjusted R2 in a linear regression model adjusted by demographics and baseline clinical characteristics. Results A total of 271 SSc and IPF patients were analysed. Correlation coefficients of highest magnitude were observed in the SSc study between the extent of ground glass, normal volume, quantification of interstitial lung disease, reticular pattern, and FVC slope (−0.25, 0.28, −0.28, and −0.33, respectively), while the correlation coefficients observed in IPF studies were in general <0.2. The incremental prognostic value of the baseline HRCT metrics was marginal after adjusting baseline characteristics and was inconsistent across study arms. Conclusion Data from the SSc and IPF studies suggested weak to no and inconsistent correlation between quantitative HRCT metrics derived by the Imbio LTA tool and FVC slope in the studied SSc and IPF population.
first_indexed 2024-03-11T10:52:36Z
format Article
id doaj.art-df885346bb274c64b06723dd75925756
institution Directory Open Access Journal
issn 2312-0541
language English
last_indexed 2024-03-11T10:52:36Z
publishDate 2023-10-01
publisher European Respiratory Society
record_format Article
series ERJ Open Research
spelling doaj.art-df885346bb274c64b06723dd759257562023-11-13T14:27:50ZengEuropean Respiratory SocietyERJ Open Research2312-05412023-10-019510.1183/23120541.00210-202300210-2023Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseasesYixuan Zou0Xuefeng Hou1Neha Anegondi2Mohammadreza Negahdar3Dorothy Cheung4Paula Belloni5Alex de Crespigny6Alexandre Fernandez Coimbra7 Product Development Data Sciences, Genentech, Inc., South San Francisco, CA, USA Product Development Data Sciences, Genentech, Inc., South San Francisco, CA, USA Clinical Imaging Group, Genentech, Inc., South San Francisco, CA, USA Artificial Intelligence, Genentech, Inc., South San Francisco, CA, USA Clinical Science, Genentech, Inc., South San Francisco, CA, USA Clinical Science, Genentech, Inc., South San Francisco, CA, USA Clinical Imaging Group, Genentech, Inc., South San Francisco, CA, USA Clinical Imaging Group, Genentech, Inc., South San Francisco, CA, USA Background Identifying systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF) patients at risk of more rapid forced vital capacity (FVC) decline could improve trial design. The purpose of the present study was to explore the prognostic value of quantitative high-resolution computed tomography (HRCT) metrics derived by Imbio lung texture analysis (LTA) tool in predicting FVC slope. Methods This retrospective study used data from patients who were not treated with investigational drugs with and without background antifibrotic therapies in tocilizumab phase 3 SSc, lebrikizumab phase 2 IPF, and zinpentraxin alfa phase 2 IPF studies conducted from 2015 to 2021. Controlled HRCT axial volumetric multidetector computed tomography scans were evaluated using the Imbio LTA tool. Associations between HRCT metrics and FVC slope were assessed through the Spearman correlation coefficient and adjusted R2 in a linear regression model adjusted by demographics and baseline clinical characteristics. Results A total of 271 SSc and IPF patients were analysed. Correlation coefficients of highest magnitude were observed in the SSc study between the extent of ground glass, normal volume, quantification of interstitial lung disease, reticular pattern, and FVC slope (−0.25, 0.28, −0.28, and −0.33, respectively), while the correlation coefficients observed in IPF studies were in general <0.2. The incremental prognostic value of the baseline HRCT metrics was marginal after adjusting baseline characteristics and was inconsistent across study arms. Conclusion Data from the SSc and IPF studies suggested weak to no and inconsistent correlation between quantitative HRCT metrics derived by the Imbio LTA tool and FVC slope in the studied SSc and IPF population.http://openres.ersjournals.com/content/9/5/00210-2023.full
spellingShingle Yixuan Zou
Xuefeng Hou
Neha Anegondi
Mohammadreza Negahdar
Dorothy Cheung
Paula Belloni
Alex de Crespigny
Alexandre Fernandez Coimbra
Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases
ERJ Open Research
title Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases
title_full Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases
title_fullStr Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases
title_full_unstemmed Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases
title_short Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases
title_sort weak to no correlation between quantitative high resolution computed tomography metrics and lung function change in fibrotic diseases
url http://openres.ersjournals.com/content/9/5/00210-2023.full
work_keys_str_mv AT yixuanzou weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases
AT xuefenghou weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases
AT nehaanegondi weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases
AT mohammadrezanegahdar weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases
AT dorothycheung weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases
AT paulabelloni weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases
AT alexdecrespigny weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases
AT alexandrefernandezcoimbra weaktonocorrelationbetweenquantitativehighresolutioncomputedtomographymetricsandlungfunctionchangeinfibroticdiseases